semaglutide and cardiovascular disease Outcomes in Patients with Type 2 Diabetes Semaglutide and Cardiovascular Health |

GHK-Cu & KPV Blend $180.00 GHK-Cu & KPV blend is a dual-peptide blend containing copper(II)-binding tripeptide (GHK-Cu 50mg) and alpha-MSH C-terminal tripeptide fragment (KPV 20mg)

Patients may also choose to self-pay for labs if preferred

#GLP1 #MetabolicHealth #CardiometabolicHealth To view or add a comment, sign in On GLP-1 meds

Optimal vitamin D3 levels can help improve your mood, boost your brain function, and generally improve your well-being

The REWIND cardiovascular outcome trial also revealed that dulaglutide administration resulted in inferior ocular outcomes, leading to an increased need for interventions such as photocoagulation, anti-vascular endothelial growth factor (VEGF) therapy, or vitrectomy compared to placebo recipients [38]

"Your skin is a mirror of whats happening inside you